247 filings
Page 7 of 13
8-K
k4y8v2555oj6
17 Jul 17
Departure of Directors or Certain Officers
12:00am
8-K
tdw72exyd89ujce
10 Jul 17
NewLink Genetics Receives Notice of Allowance from USPTO Covering Indoximod Salts and Prodrugs
12:00am
8-K
msj13vy6
23 Jun 17
Other Events
12:00am
8-K
zleamf5zrv ff9
8 Jun 17
Other Events
12:00am
8-K
q35bydr9
5 Jun 17
Other Events
12:00am
8-K
6ild22 rwwmcb
2 Jun 17
Results from Clinical Trial of Indoximod Plus Chemotherapy for Patients with Metastatic Breast Cancer
12:00am
8-K
o3erzxgl7a
18 May 17
Other Events
12:00am
8-K
ni3x636 i2fmlto8v4g
17 May 17
Data from Clinical Studies of NewLink Genetics’ Two Distinct IDO Pathway Inhibitors to Be Presented at ASCO 2017
12:00am
8-K
q8v58ejl n86hqo2id2
17 May 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
487a6u7q3371 admcz1k
4 May 17
NewLink Genetics Reports First Quarter 2017 Financial Results and Updates Clinical Trial Guidance
12:00am
8-K
ecy2kjtjmibq
4 Apr 17
Other Events
12:00am
8-K
gbhrthx
20 Mar 17
Entry into a Material Definitive Agreement
12:00am
8-K
zr6gg
1 Mar 17
NewLink Genetics Announces Presentation of Two Abstracts at AACR
12:00am
8-K
v7df8yt z8xnr
28 Feb 17
Results of Operations and Financial Condition
12:00am
8-K
hr1bip47y ps141t7rq
5 Jan 17
Departure of Directors or Certain Officers
12:00am
8-K/A
1soo226hrp qf9cyu3et
13 Dec 16
Entry into a Material Definitive Agreement
12:00am
8-K
ujm0bjqjco znygx
29 Nov 16
Entry into a Material Definitive Agreement
12:00am
8-K
hiugtq j4ori1m
1 Nov 16
NewLink Genetics Corporation Provides Operational Update and Reports Third Quarter 2016 Financial Results
12:00am
8-K
tmx8dg9qdtf
25 Oct 16
NewLink Genetics Shares Its Immuno-Oncology Strategy
12:00am
8-K
myqc0i6lo r75
4 Oct 16
Other Events
12:00am